Expression vector of human MAFG.
Alternative name | SET-0065_6 |
---|---|
Clone info. | Expression vector of human MAFG. Expression was confirmed by Western blotting with anti-FLAG antibody. |
Comment | Derived from Sugano BC012327. PCR cloning, forward primer: ATGACGACCCCCAATAAAGG; reverse primer: CTACGATCGGGCATCCGTCT. |
Vector backbone | pCMV_S-FLAG (RDB05956) (Plasmid) |
Size of vector backbone | 5.5 kb |
Selectable markers | Amp^r (E. coli), Neo^r (mammalian cell) |
Growth conditions | 37C, LB+Amp |
Gene/insert name | Human MAFG cDNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB06413.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() MTA, for use for for-profit purpose [Word ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | The RECIPIENT agrees to describe RIKEN BRC as the source of the MATERIAL and cite Gene 200, 149-156, 1997 in any publication. Additional terms and conditions: Regrding pRc/CMV: a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only. b) LIFE MATERIALS shall not be used for any commercial purposes. c) LIFE MATERIALS shall not be transferred beyond the specified recipient. d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 提供同意書 (MTA, 営利目的用)[Word ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 発表に際し、理研BRCから入手したことを明記し、指定する文献(Gene, 200, 149-156 (1997))を引用すること。 付加的使用条件: pRc/CMVについて: a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only. b) LIFE MATERIALS shall not be used for any commercial purposes. c) LIFE MATERIALS shall not be transferred beyond the specified recipient. d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above. |
Catalog # | Resource name | Shipping form | Fee |
---|---|---|---|
RDB06413 | pCMFlag_hsMAFG | DNA solution |
JPY 9,460 (not-for-profit academic purpose) JPY 18,920 (for-profit-research purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pCMFlag_hsMAFG was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB06413). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB13708_A5Kap1.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CMV-Forward Sequence file: RDB13708_A5Kaa.seq ![]() |
---|
>06413_13708_A5Ka_CMV-Forward_A05_02.ab1 1 ATTAACTCGC CCATTGACGC AATGGGCGGT AGGCGTGTAC GGTGGGAGGT CTATATAAGC 61 AGAGCTCTCT GGCTAACTAG AGAACCCACT GCTTACTGGC TTATCGAAAT TAATACGACT 121 CACTATAGGG AGACCCAAGC TGAATTCACC ATGGACTACA AGGACGATGA CGATAAGGCG 181 GCCATGACGA CCCCCAATAA AGGAAACAAG GCCTTGAAGG TGAAGCGGGA GCCGGGTGAG 241 AATGGCACCA GCCTGACGGA TGAGGAGCTG GTGACCATGT CGGTGCGGGA GCTGAACCAG 301 CACCTGCGGG GCCTGTCCAA GGAGGAGATC GTCCAGCTGA AGCAGCGCCG GCGCACGCTC 361 AAGAACCGCG GCTACGCTGC CAGCTGCCGC GTGAAGCGGG TGACGCAGAA GGAGGAGCTG 421 GAGAAGCAGA AGGCGGAGCT GCAGCAGGAG GTGGAGAAGC TGGCCTCAGA GAACGCCAGC 481 ATGAAGCTGG AGCTCGACGC GCTGCGCTCC AAGTACGAGG CGCTGCAGAC CTTCGCCCGG 541 ACGGTGGCCC GCAGCCCCGT GGCGCCAGCC CGGGGCCCCC TTGCCGCCGG CCTGGGGCCC 601 CTCGTCCCAG GCAAGGTGGC CGCCACCAGC GTCATCACAA TAGTAAAGTC CAAGACGGAT 661 GCCCGATCGT AGGGCCGCTC GAGCATGCAT CTAGAGGGCC CTATTCTATA GTGTCACCTA 721 AATGCTAGAG CTCGCTGATC AGCCTCGACT GTGCCTTCTA GTTGCCAGCC ATCTGTTGTT 781 TGCCCCTCCC CCGTGCCTTC CTTGACCCTG GAAGGTGCCA CTCCCACTGT CCTTTCCTAA 841 TAAAATGAGG AAATTGCATC GCATTGTCTG AGTATGTGTC ATTCTATTCT GGGGTGTGGT 901 TTAGCCAGGA CAGCAAGGGG GGGGAGGGAT TGGGAAGACC ATAGCAGGGC ATGCTGGGGA 961 ATGCGTGGGC TCTATGGCTT CCTGAGGCGG AAGAACCTAG CTGGAGCTCG AAGGGGAATC 1021 GCCACGTCGC CTGTAGCGGC CGCATT // |
Primer: SV40pro_F_V2 Sequence file: RDB13708_A5Kab.seq ![]() |
>06413_13708_A5Ka_SV40pro_F_V2_B05_05.ab1 1 GGGGACGTTT TGGAGCTAGG CTTTTGCAAA AGCTCCCGGG AGCTTGGATA TCCATTTTCG 61 GATCTGATCA AGAGACAGGA TGAGGATCGT TTCGCATGAT TGAACAAGAT GGATTGCACG 121 CAGGTTCTCC GGCCGCTTGG GTGGAGAGGC TATTCGGCTA TGACTGGGCA CAACAGACAA 181 TCGGCTGCTC TGATGCCGCC GTGTTCCGGC TGTCAGCGCA GGGGCGCCCG GTTCTTTTTG 241 TCAAGACCGA CCTGTCCGGT GCCCTGAATG AACTGCAGGA CGAGGCAGCG CGGCTATCGT 301 GGCTGGCCAC GACGGGCGTT CCTTGCGCAG CTGTGCTCGA CGTTGTCACT GAAGCGGGAA 361 GGGACTGGCT GCTATTGGGC GAAGTGCCGG GGCAGGATCT CCTGTCATCT CACCTTGCTC 421 CTGCCGAGAA AGTATCCATC ATGGCTGATG CAATGCGGCG GCTGCATACG CTTGATCCGG 481 CTACCTGCCC ATTCGACCAC CAAGCGAAAC ATCGCATCGA GCGAGCACGT ACTCGGATGG 541 AAGCCGGTCT TGTCGATCAG GATGATCTGG ACGAAGAGCA TCAGGGGCTC GCGCCAGCCG 601 AACTGTTCGC CAGGCTCAAG GCGCGCATGC CCGACGGCGA GGATCTCGTC GTGACCCATG 661 GCGATGCCTG CTTGCCGAAT ATCATGGTGG AAAATGGCCG CTTTTCTGGA TTCATCGACT 721 GTGGCCGGCT GGGTGTGGCG GACCGCTATC AGGACATAGC GTTGGCTACC CGTGATATTG 781 CTGAAGAGCT TGGCGGCGAA TGGGCTGACC GCTTCCTCGT GCTTTACGGT ATCGCCGCTC 841 CCGATTCGCA GCGCATCGCC TTCTATCGCC TTCTTGACGA GTTCTTCTGA GCGGGACTCT 901 GGGGGTTCGA AATGACCGAC CAAGCGACGC CCAACCTGCC ATCACGAGAT TTCGATTCCA 961 CCGCCGCCCT TCTATGAAGG GTTTGGGGCT TCGGAATCGT TTTCCCGGGG ACGCCCGGCT 1021 GGATTGATTC CTTCCAGCGG CGGGGATCTC AATGCTGGGA AGTCCATCGG CCCAACCCCA 1081 ACTTGTTTTA TTTGCCAGGC GCCAG // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content